{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T18:42:00Z","timestamp":1649097720912},"reference-count":0,"publisher":"PAGEPress Publications","issue":"1","license":[{"start":{"date-parts":[[2016,1,26]],"date-time":"2016-01-26T00:00:00Z","timestamp":1453766400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Monaldi Arch Chest Dis"],"abstract":"<jats:p>Background. The aim of our study was to identify predictive factors for the development of residual pleural thickening (RPT) in patients with tuberculous pleurisy (TP). Methods. A retrospective study of patients with pleural tuberculosis. The clinical and radiological characteristics, and measurements of microbiological and biochemical parameters or markers such as adenosine deaminase (ADA), interferon-\u03b3 (IFN-\u03b3) and vascular endothelial growth factor (VEGF) in pleural fluid were studied. Results. Thirty one patients (24 male and 7 female) with a mean age of 55.9 years were studied. There were 25 (80.6%) patients with RPT &amp;gt; 2 mm and 6 (19.4%) patients without RPT. Ten patients (32.2%) had RPT \u2265 10 mm. The rate of pleural thickening was less in small effusions (p&amp;lt;0.05). IFN-\u03b3 was higher in patients with RPT \u2265 10 mm (p &amp;lt; 0.05) in comparison with those with RPT &amp;lt; 10 mm. Conclusions. Pleural fluid IFN-\u03b3 may deserve further investigation in order to build up preventive and therapeutic strategies against RPT and its clinical complications.<\/jats:p>","DOI":"10.4081\/monaldi.2008.407","type":"journal-article","created":{"date-parts":[[2016,1,26]],"date-time":"2016-01-26T20:12:37Z","timestamp":1453839157000},"source":"Crossref","is-referenced-by-count":1,"title":["Could IFN-\u03b3 predict the development of residual pleural thickening in tuberculous pleurisy?"],"prefix":"10.4081","volume":"69","author":[{"given":"I.","family":"Gerogianni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Papala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Tsopa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Zigoulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Dimoulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Kostikas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Kiropoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.I.","family":"Gourgoulianis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2549","published-online":{"date-parts":[[2016,1,26]]},"container-title":["Monaldi Archives for Chest Disease"],"original-title":[],"link":[{"URL":"http:\/\/monaldi-archives.org\/index.php\/macd\/article\/viewFile\/407\/395","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2016,1,26]],"date-time":"2016-01-26T20:15:50Z","timestamp":1453839350000},"score":1,"resource":{"primary":{"URL":"http:\/\/monaldi-archives.org\/index.php\/macd\/article\/view\/407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,26]]},"references-count":0,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2008,3,30]]}},"URL":"https:\/\/doi.org\/10.4081\/monaldi.2008.407","relation":{},"ISSN":["2465-1028","1122-0643"],"issn-type":[{"value":"2465-1028","type":"electronic"},{"value":"1122-0643","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1,26]]}}}